自选
模拟交易
选股器
热力图
机构追踪

美股市场个股详情

ASND Ascendis Pharma A/S

添加自选

166.580
+1.700+1.03%

收盘价 04/29 16:00 (美东)

166.000
-0.580-0.35%

盘后 20:01 (美东)

100.16亿总市值-22.40市盈率TTM

关于Ascendis Pharma A/S公司

Ascendis Pharma AS是一家生物制药公司，应用其TransCon技术平台为患者带来有意义的改变。该公司的产品线包括内分泌学和肿瘤学，其中包括TransCon PTH， TransCon CNP等。该公司在北美、欧洲和世界其他地区开展业务，其大部分收入来自北美。

公司介绍

公司代码ASND

公司名称Ascendis Pharma A/S

上市日期2015/01/28

发行价格18.00

成立日期2006

CEOMr. Jan Moller Mikkelsen

所属市场纳斯达克

员工数量1017

证券类型存托凭证

ADS转换比例1.0 : 1.0

年结日12-31

公司地址Tuborg Boulevard 12

城市Hellerup

省份首都地区

国家丹麦

邮编2900

电话45-70-22-22-44

网址http://www.ascendispharma.com

董事高管

姓名
职务
年薪

Jan Moller Mikkelsen
President, Chief Executive Officer and Director
--

Lotte Sonderbjerg
Executive Vice President and Chief Administrative Officer
--

Aimee Shu
Executive Vice President and Chief Medical Officer
--

Scott T Smith
Executive Vice President and Chief Financial Officer
--

Michael Wolff Jensen
Executive Vice President and Chief Legal Officer
--

Mads Bodenhoff
Senior Vice President, Head of Finance and Principal Accounting Officer
--

Jay Donovan Wu
Executive Vice President and U.S. President
--

Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
--

Dr. Stina Singel, M.D.
Executive Vice President and Head of Clinical Development, Oncology
--

Dr. Kennett Sprogoe, PhD
Executive Vice President and Head of Innovation and Research
--

Dr. Albert Cha, M.D.,PhD
Chairman of the Board
--

Siham Imani
Independent Director
--

Lisa Bright
Independent Director
--

William Carl Fairey, Jr
Independent Director
--

Lars Holtug
Independent Director
--